Azathioprine is a synthetic purine analog that functions as a prodrug of 6-mercaptopurine. It is administered to suppress excessive immune activity in conditions such as organ transplant rejection and autoimmune diseases. After oral ingestion the drug is metabolized by hepatic enzymes to the active metabolite 6-mercaptopurine which is then converted to thio-inosinic acid within lymphocytes. Thio-inosinic acid inhibits de novo purine synthesis by antagonizing the activity of xanthine oxidase and by being incorporated into dna and rna leading to cytotoxicity in proliferating cells. The resulting depletion of guanine nucleotides impairs nucleic acid synthesis and prompts apoptosis of overactive immune cells. This targeted reduction of lymphocyte proliferation translates into the therapeutic effect of preventing graft rejection and modulating autoimmune pathology.

Azathioprine is an immunosuppressive medication used primarily to prevent organ transplant rejection and to treat certain autoimmune diseases. It belongs to the class of purine analogues that interfere with dna and rna synthesis in rapidly dividing immune cells. After oral administration the drug is converted by the hepatic pathway into 6-mercaptopurine which then is metabolized to active thioguanine nucleotides. These active metabolites inhibit several steps in purine biosynthesis leading to reduced proliferation of t lymphocytes. The suppression of t-cell activity modulates immune responses and helps maintain graft tolerance or diminish inflammatory attacks. Pharmacokinetically Azathioprine exhibits moderate oral absorption and a variable half-life influenced by individual metabolism. Genetic polymorphisms in the thiopurine methyltransferase enzyme can affect the clearance of the drug and its therapeutic efficacy. Overall it functions as a prodrug that ultimately limits immune cell activation through depletion of guanine nucleotides needed for nucleic acid synthesis.

Azathioprine is sometimes prescribed to modulate the immune system. Common side effects include nausea, vomiting and mild liver enzyme elevation. Some individuals may experience skin rashes or itching without an allergic reaction. Blood cell counts can decrease leading to increased susceptibility to infections. Elevated uric acid levels may cause gout-like joint discomfort in certain patients. Regular monitoring of kidney function is recommended because the drug can affect renal clearance.

Azathioprine can cause nausea and vomiting in some patients. It may lower white blood cell counts increasing infection risk. The drug can affect liver function leading to elevated enzymes. Some individuals experience skin rash or itching as a reaction. Rarely it may cause pancreatitis requiring medical attention. Long term use has been linked to a slight increase in malignancy risk. Patients are monitored regularly for blood work and organ function.